Li Wang

Nanjing Medical University - Department of Hematology

300 Guangzhou Road

Nanjing, Jiangsu 210029

China

SCHOLARLY PAPERS

2

DOWNLOADS

87

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

The Impacts of Zanubrutinib on Immune Cells in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Number of pages: 36 Posted: 10 Jul 2019
Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology and Shanghai University - Institute of ADR and Arbitration
Downloads 44 (905,092)

Abstract:

Loading...

2.

Dose-Adjusted EPOCH Regimen as First-Line Treatment for Non-Hodgkin's Lymphoma with Hemophagocytic Lymphohistiocytosis: A Single-Arm, Open-Label, Phase 2 Trial

Number of pages: 51 Posted: 14 Feb 2019
Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Jiangsu University, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Jiangsu Province Hospital - Department of Hematology, Nanjing Medical University - First Affiliated Hospital and The First Affiliated Hospital of Nanjing Medical University - Department of Hematology
Downloads 43 (914,165)

Abstract:

Loading...

hemophagocytic lymphohistiocytosis; non-Hodgkin's lymphoma; DAEPOCH; autologous stem cell transplantation; phase II study